glp-1 news 2025 november 25 Stopping and restarting GLP-1s may make it less effective GLP-1 Pipeline Update: November 2025

As we navigate these complexities, a multidisciplinary approach will be crucial in shaping a future: where GLP-1 receptor agonists can be used responsibly and equitably, advancing health outcomes while minimising unintended societal repercussions

The mechanism that lowers postprandial glucose also means the stomach retains contents longer, which is relevant to anyone with pre-existing gastroparesis or significant GI motility disorders, and is a theoretical consideration around procedures requiring an empty stomach

By improving insulin sensitivity and nutrient utilization, IGF-1 LR3 may support fat reduction but its not a fat burner and comes with high risks

Parikh, and G.A

doi: 10.1016/j.bbi.2012.02.008 424 BalinasCEaton-FitchNMaksoudRStainesDMarshall-GradisnikS